Cargando…
Molecular Mechanisms and Biomarkers Associated with Chemotherapy-Induced AKI
Acute kidney injury (AKI) is a life-threatening condition characterized by a rapid and transient decrease in kidney function. AKI is part of an array of conditions collectively defined as acute kidney diseases (AKD). In AKD, persistent kidney damage and dysfunction lead to chronic kidney disease (CK...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910619/ https://www.ncbi.nlm.nih.gov/pubmed/35269781 http://dx.doi.org/10.3390/ijms23052638 |
_version_ | 1784666536836857856 |
---|---|
author | De Chiara, Letizia Lugli, Gianmarco Villa, Gianluca Raglianti, Valentina Husain-Syed, Faeq Ravaglia, Fiammetta Romagnani, Paola Lazzeri, Elena |
author_facet | De Chiara, Letizia Lugli, Gianmarco Villa, Gianluca Raglianti, Valentina Husain-Syed, Faeq Ravaglia, Fiammetta Romagnani, Paola Lazzeri, Elena |
author_sort | De Chiara, Letizia |
collection | PubMed |
description | Acute kidney injury (AKI) is a life-threatening condition characterized by a rapid and transient decrease in kidney function. AKI is part of an array of conditions collectively defined as acute kidney diseases (AKD). In AKD, persistent kidney damage and dysfunction lead to chronic kidney disease (CKD) over time. A variety of insults can trigger AKI; however, chemotherapy-associated nephrotoxicity is increasingly recognized as a significant side effect of chemotherapy. New biomarkers are urgently needed to identify patients at high risk of developing chemotherapy-associated nephrotoxicity and subsequent AKI. However, a lack of understanding of cellular mechanisms that trigger chemotherapy-related nephrotoxicity has hindered the identification of effective biomarkers to date. In this review, we aim to (1) describe the known and potential mechanisms related to chemotherapy-induced AKI; (2) summarize the available biomarkers for early AKI detection, and (3) raise awareness of chemotherapy-induced AKI. |
format | Online Article Text |
id | pubmed-8910619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89106192022-03-11 Molecular Mechanisms and Biomarkers Associated with Chemotherapy-Induced AKI De Chiara, Letizia Lugli, Gianmarco Villa, Gianluca Raglianti, Valentina Husain-Syed, Faeq Ravaglia, Fiammetta Romagnani, Paola Lazzeri, Elena Int J Mol Sci Review Acute kidney injury (AKI) is a life-threatening condition characterized by a rapid and transient decrease in kidney function. AKI is part of an array of conditions collectively defined as acute kidney diseases (AKD). In AKD, persistent kidney damage and dysfunction lead to chronic kidney disease (CKD) over time. A variety of insults can trigger AKI; however, chemotherapy-associated nephrotoxicity is increasingly recognized as a significant side effect of chemotherapy. New biomarkers are urgently needed to identify patients at high risk of developing chemotherapy-associated nephrotoxicity and subsequent AKI. However, a lack of understanding of cellular mechanisms that trigger chemotherapy-related nephrotoxicity has hindered the identification of effective biomarkers to date. In this review, we aim to (1) describe the known and potential mechanisms related to chemotherapy-induced AKI; (2) summarize the available biomarkers for early AKI detection, and (3) raise awareness of chemotherapy-induced AKI. MDPI 2022-02-27 /pmc/articles/PMC8910619/ /pubmed/35269781 http://dx.doi.org/10.3390/ijms23052638 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review De Chiara, Letizia Lugli, Gianmarco Villa, Gianluca Raglianti, Valentina Husain-Syed, Faeq Ravaglia, Fiammetta Romagnani, Paola Lazzeri, Elena Molecular Mechanisms and Biomarkers Associated with Chemotherapy-Induced AKI |
title | Molecular Mechanisms and Biomarkers Associated with Chemotherapy-Induced AKI |
title_full | Molecular Mechanisms and Biomarkers Associated with Chemotherapy-Induced AKI |
title_fullStr | Molecular Mechanisms and Biomarkers Associated with Chemotherapy-Induced AKI |
title_full_unstemmed | Molecular Mechanisms and Biomarkers Associated with Chemotherapy-Induced AKI |
title_short | Molecular Mechanisms and Biomarkers Associated with Chemotherapy-Induced AKI |
title_sort | molecular mechanisms and biomarkers associated with chemotherapy-induced aki |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910619/ https://www.ncbi.nlm.nih.gov/pubmed/35269781 http://dx.doi.org/10.3390/ijms23052638 |
work_keys_str_mv | AT dechiaraletizia molecularmechanismsandbiomarkersassociatedwithchemotherapyinducedaki AT lugligianmarco molecularmechanismsandbiomarkersassociatedwithchemotherapyinducedaki AT villagianluca molecularmechanismsandbiomarkersassociatedwithchemotherapyinducedaki AT ragliantivalentina molecularmechanismsandbiomarkersassociatedwithchemotherapyinducedaki AT husainsyedfaeq molecularmechanismsandbiomarkersassociatedwithchemotherapyinducedaki AT ravagliafiammetta molecularmechanismsandbiomarkersassociatedwithchemotherapyinducedaki AT romagnanipaola molecularmechanismsandbiomarkersassociatedwithchemotherapyinducedaki AT lazzerielena molecularmechanismsandbiomarkersassociatedwithchemotherapyinducedaki |